《萬寶盛華(MPG):2024年全球醫療健康與生命科學行業職場展望報告(英文版)(12頁).pdf》由會員分享,可在線閱讀,更多相關《萬寶盛華(MPG):2024年全球醫療健康與生命科學行業職場展望報告(英文版)(12頁).pdf(12頁珍藏版)》請在三個皮匠報告上搜索。
1、1Healthcare and Life Sciences World of Work 2024 Outlook 77%OF HEALTHCARE AND LIFE SCIENCES EMPLOYERS ARE STRUGGLING TO FIND THE SKILLED TALENT THEY NEEDGlobal InsightsOF HEALTHCARE AND LIFE SCIENCES ORGANIZATIONS ARE STRUGGLING TO ACHIEVE THEIR BUSINESS GOALS75%10 Million MORE HEALTHCARE WORKERS AR
2、E NEEDED BY 2030Manpower|Experis|Talent Solutions2ContentsINTRODUCTIONCONCLUSIONA Prognosis of More AI AdoptionTREND ONEComing of AgeTREND TWOInoculating Against Supply Chain DisruptionTREND THREESecond OpinionsTREND FOURAn Rx for PxTREND FIVEGLP-1 Has Just BegunTREND SIXMedication RegulationTREND S
3、EVEN3Transformation within the healthcare and life sciences sector continues to be driven by technological advancements and changing consumer behaviors.As we move further into 2024,these trends are shaping the industry in new and exciting ways.We will explore how global industry leaders will leverag
4、e accelerating innovation to create more patient-centric care and drive transformative advancements.For each trend,we will also examine the impact on the future of work.How will accelerating AI adoption impact the future of healthcare innovation and required workforce skills?How can the industry sca
5、le up to meet the growing healthcare demands of aging populations around the world?What is the impact of increasing global macroeconomic and supply chain complexity on the future of work in this industry?INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION4A Pr
6、ognosis of More AI AdoptionThis shift towards AI-driven healthcare is expected to improve efficiency,accelerate drug development,reduce burnout,and potentially equalize access to care,especially in underserved areas.However,the integration of AI also demands a workforce that is adept at working alon
7、gside advanced technologies,necessitating ongoing education and adaptation.The Opportunity is Now:Today,only 38%of employers in the healthcare and life sciences sector globally say they are using conversational AI tools such as ChatGPT,which is well below the average current adoption rate(48%)for al
8、l industries.But the race is on with 22%of healthcare and life sciences employers planning to deploy these tools in the next 12 months and 14%saying they plan to do so in three years.1 Employers Identify Top Adoption Barriers:Healthcare and Life Sciences employers say high costs(34%),concerns about
9、privacy or regulation(34%)and current employee skills gaps(31%)are the top challenges as they seek to accelerate AI adoption within their business.Employers in this sector were also more concerned about privacy,regulation and employee resistance to change(29%)than other industries.1 A“Wait and See”D
10、iagnosis:When employers were asked to predict the impact of AI on key outcomes such as business performance,employee engagement and headcount,healthcare and life sciences respondents were the most pessimistic industry.However,most(51%)believe it will have a positive impact on overall headcount in th
11、e next two years.1HEALTHCARE AND LIFE SCIENCES EMPLOYERS ARE LESS OPTIMISTIC ABOUT AI THAN OTHER INDUSTRIES,BUT MOST(51%)STILL BELIEVE IT WILL CREATE JOBS IN THE NEXT TWO YEARS.1Workforce Implications:Relative AI pessimism within this sector offers an opportunity to differentiate,by more closely eng
12、aging employees in AI innovation.The right skilled talent can help overcome the privacy and regulatory risks,which are typically greater for businesses in this industry.A focus on managing strategic workforce planning fundamentals(e.g.,upskilling and reskilling,contingent workforce)can help organiza
13、tions find the cost efficiencies needed to sustain investment in AI innovation.1.ManpowerGroup Employment Outlook Survey,Q3 2024INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION5Coming of AgeThe aging of the worlds population is exerting a profound impact on
14、 global healthcare systems.As life expectancy increases and birth rates decline,the proportion of older populations is rising rapidly.Healthcare services are facing mounting pressures,including increased demand for long-term care,higher healthcare expenditures,provider retirements,and a shifting dis
15、ease burden.This trend will also constrain the workforce supply for the foreseeable future.The Golden Years:As life expectancy increases and birth rates decline,the proportion of older populations is rising rapidly,with those aged 60 and over expected to double from 12%to 22%between 2015 and 2050.In
16、 2050,80%of 60+population will live in low-and middle-income countries.1 An Aging Workforce:By 2030,workforce aging will mean 150 million jobs will be now filled by workers over the age of 55.That figure is nearly equal to the entire working population of the US.In the Group of Seven(G7),experienced
17、 workers in these countries will comprise a quarter of the workforce by the end of the decade.Consequently,health and well-being to promote longevity will become increasingly important for employers.2 Growing Talent Needs:The global healthcare sector is facing a critical shortage of workers.By 2030,
18、the World Health Organization(WHO)estimates the shortfall will grow to 10 million and disproportionately impact low and lower-middle income countries.3 Workforce Implications:Employers and policymakers around the world must innovate to educate,train,hire,and deploy more healthcare workers to meet th
19、e needs of aging populations.Workers in the healthcare and life sciences sector say they experience more daily stress than any other industry.At the same time,they are also the most likely to find meaning in their work.4 Employers must navigate this challenge to improve retention.A focus on diversit
20、y,equity,inclusion and belonging is not just the right thing to do in this sector,its a necessity to maximize talent pipelines amid persistent talent scarcity.1.World Health Organization 2.Bain&Company 3.World Health Organization 4.ManpowerGroup Workforce Survey,May 2024THE HEALTHCARE AND LIFE SCIEN
21、CES SECTOR MUST SCALE UP TO MEET THE NEEDS OF A RAPIDLY AGING GLOBAL POPULATION.1INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION6Inoculating Against Supply Chain DisruptionThe healthcare and life sciences industry is revamping its supply chains to be more
22、resilient in the face of disruptions.This includes a shift toward localization bringing production of critical materials closer to manufacturing sites.Additionally,companies are embracing digitalization by using real-time data to track inventory and predict potential shortages.Sustainability is also
23、 a growing concern,with efforts being made to diversify supplier bases and mitigate climate risks.These trends aim to create a more agile and responsive supply chain that can navigate future challenges and ensure patients receive the vital treatments they need.Growing Momentum in the Americas:In 202
24、2,reshoring and foreign direct manufacturing job announcements in the U.S.reached the highest rate ever recorded,with a total of 360,000+new jobs created,representing a 53%increase from 2021.In the medical industry alone,105 companies announced new facilities which will create more than 14,000 new j
25、obs.1 Europe Takes Action:The European Commission recently formed a Critical Medicines Alliance to identify medicines vulnerable to global supply chain disruptions and identify opportunities to streamline regulation and consider incentives to boost local production of key drugs.2 Pharma-Focused:The
26、overall Net Employment Outlook(NEO)the net of employers planning to hire vs.those planning headcount reductions improved slightly by 1%,totaling 27%for Q3 2024.However,strong global hiring demand in pharmaceuticals stood out with 50%vs.the previous year in Q3 2024.3 Workforce Implications:Growing su
27、pply chain complexity necessitates skilled professionals who can manage logistics,regulatory compliance,risk assessment,and vendor relationships.Demand for expertise in data analytics,digital technologies,and supply chain optimization has increased.Location strategy is an important consideration.New
28、 research from CBRE4 encourages employers to consider smaller medical innovation hubs and tools such as the Total Workforce Index to help.1.The Reshoring Initiative 2.European Commission 3.ManpowerGroup Employment Outlook Survey,Q3 2024 4.CBRERESHORING AND LOCALIZATION OF THE MEDICAL SUPPLY CHAIN WI
29、LL BE A KEY JOB CREATOR IN MANY COUNTRIES.2INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION7Second Opinions The current outlook for healthcare and life sciences offers a future of both unprecedented opportunity and uncertainty.Advancements in AI,genomics,an
30、d digital health technologies point toward a future of personalized medicine,preventive care,and more effective treatments.At the same time,a challenging global business environment increases the urgency for business transformation,human capital engagement,strategic acquisitions,and divestment.Conti
31、nued Era of M.D.(Mergers&Divestments):Deal volumes for life sciences and healthcare dropped from 2022 highs,with life sciences transactions declining from 1,133 to 919,and healthcare deals falling from 1,001 to 857.However,these figures still indicate a robust level of dealmaking activity.Analysts e
32、xpect strategic acquisitions and divestments to continue as major players seek to simultaneously scale and improve margins.1 Executives are Frustrated:While an overwhelming majority of healthcare leaders(90%)say AI transformation is a top priority for their organization,most(75%)say their organizati
33、ons are not yet able to deliver on that priority because they have not sufficiently planned or allocated the necessary resources.2 Talent is Still Scarce:The healthcare and life science industry struggles with talent scarcity more than any other sector.Today,77%of employers in this industry say they
34、 are struggling to find the skilled talent they need.3 Workforce Implications:If todays current business uncertainty follows historical patterns,now is the time for employers to be bold and creative.Despite potential regulatory uncertainty,an aging population and rapid technological innovation offer
35、 long-term opportunities for this sector.Focusing on fundamentals such as strategic workforce planning,retention,upskilling,and reskilling offer the potential to pay future dividends.77%OF HEALTHCARE AND LIFE SCIENCES EMPLOYERS ARE STRUGGLING TO FIND THE SKILLED TALENT THEY NEED.31.KPMG 2.McKinsey 3
36、.ManpowerGroup 2024 Global Talent Shortage SurveyINTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION8An Rx for PxThe evolution of patient experience(PX)is poised to significantly reshape the global workforce needs in healthcare and life sciences.As patients in
37、creasingly seek personalized,empathetic care,and seamless access to services,the demand for healthcare professionals who can deliver such experiences is surging.This focus on patient care is also occurring as many workers are burnt out and leaving the sector.A Triple Bottom Line:Most healthcare busi
38、ness leaders(60%)say improving patient experience is a top priority in 2024.At the same time,they also say increasing revenue(70%)and cost reduction are top priorities(55%).1 Growing Consumer Mistrust:As large investments to improve patient experience are increasing,so is consumers overall mistrust
39、of medical technology.Most(55%)say technology will have a negative impact on healthcare due to increased costs,compromised privacy and unforeseen issues.This global mistrust has increased 8%since 2018.2 Improving Worker Experience to Impact PX:Employees in the global healthcare and life sciences sec
40、tor report more stress than any other industry.More than half(52%)say they experience workplace stress on a daily basis.3Workforce Implications:Investments to better manage the stress of customer-facing frontline workers are simultaneously long-term investments to improve patient experience.Recruitm
41、ent and retention of cybersecurity expertise is critical to avoid incidents which can impact customer trust and privacy.Increase the focus on soft skills across your organization to build a more patient-centric culture.Healthcare leaders must prioritize initiatives that promote empathy,transparency,
42、and collaboration.1.Healthcare Financial Management Association 2.2024 Edelman Trust Barometer 3.ManpowerGroup Workforce Survey,May 2024MANAGING HEALTHCARE AND LIFE SCIENCES WORKER STRESS OFFERS AN OPPORTUNITY TO IMPROVE PATIENT EXPERIENCE.3INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FI
43、VETREND SIXTREND SEVENCONCLUSION9GLP-1 Has Just BegunThe market for GLP-1 drugs,a class of medications primarily used for the treatment of Type 2 diabetes and obesity,is experiencing a remarkable surge.This growth is driven by the drugs efficacy in lowering blood sugar levels,reducing appetite,and a
44、iding in weight management.As the prevalence of diabetes and obesity rises globally,the GLP-1 drug market is poised for continued expansion,with significant implications for patients,healthcare providers,and the pharmaceutical industry at large.A Recipe for Growth:Global use of GLP-1 drugs for diabe
45、tes and weight loss care has grown rapidly.Today,in the U.S.alone,1 in 8 Americans have used GLP-1 drugs.In the past year,Ozempic and Wegovy manufacturer Novo Nordisk has grown to become the most valuable company in Europe,surpassing global brands such as Louis Vuitton and ASML semiconductors.1 Just
46、 the Beginning:Despite the rapid growth,it is important to remember these drugs are still new.As researchers leverage AI to evaluate a growing volume of big data from patients,it could lead to the discovery of both,side effects and new uses for treatment(e.g.,prostate cancer).2 A Healthier Future of
47、 Work:Worldwide adult obesity has more than doubled since 1990 and adolescent obesity has quadrupled since 1990.In 2022,2.5 billion adults worldwide were overweight and 890 million were living with obesity.GLP-1 drugs add to a growing number of resources workers can access to improve their health an
48、d well-being.3 Workforce Implications:Competition for skilled talent will grow as the pharmaceutical industry works to introduce similar drugs and new treatments based on this new category of drugs.Production and distribution facility demand for workers will grow as manufacturing of these drugs cont
49、inues to scale up.Demand for medical personnel specialized in weight loss care will grow to meet the needs of the growing numbers of patients seeking to use these drugs.1.Kaiser Family Foundation 2.Fast Company 3.World Health OrganizationMORE THAN 2.5 BILLION PEOPLE WORLDWIDE STRUGGLE WITH THEIR WEI
50、GHT AND GLP-1 DRUGS OFFER NEW TOOLS TO HELP.3INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION10Medication RegulationThe healthcare and life sciences sector is facing a period of intensified regulatory scrutiny as it adapts to the rapid changes brought about
51、 by digitalization,automation,and new clinical trial models.While these advancements hold great promise,they also introduce a range of ethical and legal challenges,particularly concerning data privacy,consent,and health equity.The industrys response to the COVID-19 pandemic has shifted attitudes tow
52、ards greater collaboration,but this comes with its own set of risks,including those related to mergers and acquisitions,product safety,as well as cost and availability.Industry Concern:When employers in the healthcare and life sciences sector were asked to rank their top AI adoption challenges,respo
53、ndents around the world agreed costs and regulation were the top concerns.1 Potential Roadblocks in Europe:A growing matrix of industry regulation in Europe has the potential to slow medical device regulation.Industry leaders are very familiar with the recently enacted EU Medical Device Regulation(M
54、DR)standards.However,devices which also use AI will also need to navigate the new EU AI Act,EU General Data Protection Regulation(GDPR)and additional local laws.2 Price Negotiation:The U.S.Inflation Reduction Act(IRA)has introduced significant changes to drug pricing,particularly within the Medicare
55、 program,which could have growing implications on revenue for the worlds largest pharmaceutical manufacturers.The full impact is not yet known,and the industry may need to adjust R&D and portfolio planning.3 Workforce Implications:Potential future R&D and compliance expenses uncertainty makes managi
56、ng workforce costs increasingly important.Working with trusted partners can help offset total business risk.Future AI regulationparticularly when related to patient carewill require an increasingly skilled and agile workforce to keep up with the accelerating pace of change.1.Stanford University 2.Ma
57、npowerGroup Employment Outlook Survey,Q3 2024 3.Boston Consulting Group#1 HEALTHCARE AND LIFE SCIENCE BUSINESS LEADERS SAY COSTS AND REGULATIONS ARE THEIR TOP AI ADOPTION CONCERNS.3INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSION11Top Workforce Opportunitie
58、s in Healthcare and Life SciencesLeverage Uncertainty for Opportunity:The current global business uncertainty provides opportunities for bold leaders to invest in their future human capital.Embrace AI:General industry skepticism of AI(higher than all other industries)offers an opportunity for skille
59、d talent to find innovative solutions to leverage AI to create business differentiation.Focus on the Patient:Trusted sources such as the Edelman Trust Barometer point to growing patient skepticism of the healthcare industry.However,organizations which can earn their trust and deliver personalized ca
60、re have the opportunity to gain competitive advantage.Chill Out:The workforce in this industry is the most stressed.Employers that find innovative solutions to manage it will gain a retention and talent advantage.Get Ready:The future of the healthcare and life sciences industry is bright.Organizatio
61、ns which can navigate the significant change management and talent scarcity challenges today will have the opportunity to deliver better experiences and outcomes for patients.INTRODUCTIONTREND ONETREND TWOTREND THREETREND FOURTREND FIVETREND SIXTREND SEVENCONCLUSIONAbout Us ManpowerGroup(NYSE:MAN),t
62、he leading global workforce solutions company,helps organizations transform in a fast-changing world of work by sourcing,assessing,developing,and managing the talent that enables them to win.We develop innovative solutions for hundreds of thousands of organizations every year,providing them with ski
63、lled talent while finding meaningful,sustainable employment for millions of people across a wide range of industries and skills.Our expert family of brands Manpower,Experis,and Talent Solutions creates substantially more value for candidates and clients across more than 70 countries and territories
64、and has done so for more than 75 years.We are recognized consistently for our diversity as a best place to work for Women,Inclusion,Equality,and Disability,and in 2024 ManpowerGroup was named one of the Worlds Most Ethical Companies for the 15th time all confirming our position as the brand of choic
65、e for in-demand talent.Forward Looking Statements This report contains forward-looking statements,including statements regarding labor demand in the technology industry and use of emerging technologies.Actual events or results may differ materially from those contained in the forward-looking stateme
66、nts due to risks,uncertainties,and assumptions.These factors include those found in the Companys reports filed with the SEC,including the information under the heading“Risk Factors”in its Annual Report on Form 10-K for the year ended December 31,2023,which information is incorporated herein by reference.ManpowerGroup disclaims any obligation to update any forward-looking or other statements in this report,except as required by law.Career TransitionCareer ManagementTalent ResourcingWorkforce ManagementWorkforce Consulting&AnalyticsTop Talent AttractionGlobal Workforce Soluti